Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): 85.68%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
54.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
14.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Indivior Pharmaceuticals Inc
Market Cap
$4.48B
Return on Invested Capital (ROIC)
N/A
TTM Avg
54.58%
3Y Avg
14.13%
5Y Avg
N/A
Market Cap
$4.37B
Return on Invested Capital (ROIC)
-23.69%
TTM Avg
-46.07%
3Y Avg
-46.68%
5Y Avg
-46.68%
Market Cap
$4.60B
Return on Invested Capital (ROIC)
6.39%
TTM Avg
-7.12%
3Y Avg
-17.71%
5Y Avg
-17.71%
Market Cap
$4.64B
Return on Invested Capital (ROIC)
9.68%
TTM Avg
9.25%
3Y Avg
8.40%
5Y Avg
7.66%
Market Cap
$4.31B
Return on Invested Capital (ROIC)
-48.57%
TTM Avg
-35.38%
3Y Avg
-31.64%
5Y Avg
-25.98%
Market Cap
$4.31B
Return on Invested Capital (ROIC)
-6.67%
TTM Avg
-24.96%
3Y Avg
-29.08%
5Y Avg
-26.21%
Market Cap
$4.70B
Return on Invested Capital (ROIC)
3.03%
TTM Avg
-0.36%
3Y Avg
-5.28%
5Y Avg
-5.99%
Market Cap
$4.73B
Return on Invested Capital (ROIC)
-23.81%
TTM Avg
-42.00%
3Y Avg
-57.33%
5Y Avg
-55.42%
Market Cap
$4.78B
Return on Invested Capital (ROIC)
-18.48%
TTM Avg
-32.11%
3Y Avg
-33.07%
5Y Avg
-32.00%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indivior Pharmaceuticals Inc (INDV) | $4.48B | N/A | 54.58% | 14.13% | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | -23.69% | -46.07% | -46.68% | -46.68% |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 6.39% | -7.12% | -17.71% | -17.71% |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 9.68% | 9.25% | 8.40% | 7.66% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.31B | -48.57% | -35.38% | -31.64% | -25.98% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.31B | -6.67% | -24.96% | -29.08% | -26.21% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 3.03% | -0.36% | -5.28% | -5.99% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | -23.81% | -42.00% | -57.33% | -55.42% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.78B | -18.48% | -32.11% | -33.07% | -32.00% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.83B | -13.09% | -9.79% | -21.15% | -33.38% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-03-31 | 85.68% |
| 2025-12-31 | 95.88% |
| 2025-09-30 | 48.49% |
| 2025-06-30 | 35.93% |
| 2025-03-31 | 6.93% |
| 2024-12-31 | 10.28% |
| 2024-09-30 | 4.36% |
| 2024-06-30 | -31.36% |
| 2024-03-31 | 2.35% |
| 2023-12-31 | -0.82% |
| 2023-09-30 | -51.76% |
| 2023-06-30 | -10.89% |
| 2023-03-31 | -11.34% |
| 2022-12-31 | -11.23% |
| 2022-09-30 | 19.31% |
